Adli Karadsheh

Adli Karadsheh is a medical practice and clinical research entity led by Dr. Adli Karadsheh, a board-certified internist and specialist in allergy and immunology based in Palm Bay, Florida. Dr. Karadsheh is recognized for his extensive experience in internal medicine and his contributions to clinical research, notably serving as a sponsor and investigator for Phase 3 clinical trials involving treatments such as cromolyn sodium. His professional focus includes metabolic health, cardiovascular disease, and the management of long COVID, with a particular interest in integrating advanced technologies and AI into clinical practice. The entity provides comprehensive patient care through affiliations with major healthcare groups like OMNI Healthcare and MaxHealth.